Literature DB >> 30042222

Thrombotic Microangiopathy in a Transplant Recipient.

Venkat Ram Rakesh Mundra1, Roslyn Bernstein Mannon2.   

Abstract

Entities:  

Keywords:  Allograft Failure; Thrombotic Microangiopathies; Transplant Recipients; immunosuppression; kidney transplantation

Year:  2018        PMID： 30042222      PMCID： PMC6086698          DOI： 10.2215/CJN.00020118

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  10 in total

1.  Thrombotic microangiopathy after kidney transplantation.

Authors:  M Noris; G Remuzzi
Journal:  Am J Transplant       Date:  2010-07       Impact factor: 8.086

Review 2.  Atypical hemolytic-uremic syndrome.

Authors:  Marina Noris; Giuseppe Remuzzi
Journal:  N Engl J Med       Date:  2009-10-22       Impact factor: 91.245

3.  Pathogenic Variants in Complement Genes and Risk of Atypical Hemolytic Uremic Syndrome Relapse after Eculizumab Discontinuation.

Authors:  Fadi Fakhouri; Marc Fila; François Provôt; Yahsou Delmas; Christelle Barbet; Valérie Châtelet; Cédric Rafat; Mathilde Cailliez; Julien Hogan; Aude Servais; Alexandre Karras; Raifah Makdassi; Feriell Louillet; Jean-Philippe Coindre; Eric Rondeau; Chantal Loirat; Véronique Frémeaux-Bacchi
Journal:  Clin J Am Soc Nephrol       Date:  2016-10-31       Impact factor: 8.237

4.  Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome.

Authors:  M Le Quintrec; J Zuber; B Moulin; N Kamar; M Jablonski; A Lionet; V Chatelet; C Mousson; G Mourad; F Bridoux; E Cassuto; C Loirat; E Rondeau; M Delahousse; V Frémeaux-Bacchi
Journal:  Am J Transplant       Date:  2013-01-28       Impact factor: 8.086

5.  Haemolytic uraemic syndrome caused by factor H mutation: is single kidney transplantation under intensive plasmatherapy an option?

Authors:  Patricia Hirt-Minkowski; Stefan Schaub; Michael Mayr; Jürg A Schifferli; Michael Dickenmann; Véronique Frémeaux-Bacchi; Jürg Steiger
Journal:  Nephrol Dial Transplant       Date:  2009-07-25       Impact factor: 5.992

6.  Anti-Factor H autoantibodies in a fifth renal transplant recipient with atypical hemolytic and uremic syndrome.

Authors:  M Le Quintrec; J Zuber; L-H Noel; E Thervet; V Frémeaux-Bacchi; P Niaudet; P Niauif; W-H Fridman; C Legendre; M-A Dragon-Durey
Journal:  Am J Transplant       Date:  2009-05       Impact factor: 8.086

Review 7.  Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background.

Authors:  Elena Bresin; Erica Daina; Marina Noris; Federica Castelletti; Rumen Stefanov; Prudence Hill; Timothy H J Goodship; Giuseppe Remuzzi
Journal:  Clin J Am Soc Nephrol       Date:  2005-11-02       Impact factor: 8.237

8.  Onset and progression of de novo donor-specific anti-human leukocyte antigen antibodies after BK polyomavirus and preemptive immunosuppression reduction.

Authors:  G Dieplinger; M J Everly; K P Briley; C E Haisch; P Bolin; A Q Maldonado; W T Kendrick; S A Kendrick; C Morgan; P I Terasaki; L M Rebellato
Journal:  Transpl Infect Dis       Date:  2015-12       Impact factor: 2.228

9.  Complement mutation-associated de novo thrombotic microangiopathy following kidney transplantation.

Authors:  M Le Quintrec; A Lionet; N Kamar; A Karras; S Barbier; M Buchler; F Fakhouri; F Provost; W H Fridman; E Thervet; C Legendre; J Zuber; V Frémeaux-Bacchi
Journal:  Am J Transplant       Date:  2008-06-28       Impact factor: 8.086

10.  The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials.

Authors:  M Haas; A Loupy; C Lefaucheur; C Roufosse; D Glotz; D Seron; B J Nankivell; P F Halloran; R B Colvin; Enver Akalin; N Alachkar; S Bagnasco; Y Bouatou; J U Becker; L D Cornell; J P Duong van Huyen; I W Gibson; Edward S Kraus; R B Mannon; M Naesens; V Nickeleit; P Nickerson; D L Segev; H K Singh; M Stegall; P Randhawa; L Racusen; K Solez; M Mengel
Journal:  Am J Transplant       Date:  2018-01-21       Impact factor: 8.086
  10 in total
  1 in total

1.  Outcomes of Kidney Transplant Patients with Atypical Hemolytic Uremic Syndrome Treated with Eculizumab: A Systematic Review and Meta-Analysis.

Authors:  Maria L Gonzalez Suarez; Charat Thongprayoon; Michael A Mao; Napat Leeaphorn; Tarun Bathini; Wisit Cheungpasitporn
Journal:  J Clin Med       Date:  2019-06-27       Impact factor: 4.241
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.